Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Rani Therapeutics Holdings (RANI) Other Non Operating Income (2021)

Rani Therapeutics Holdings has reported Other Non Operating Income over the past 1 years, most recently at $1.4 million for Q4 2021.

  • Quarterly results put Other Non Operating Income at $1.4 million for Q4 2021, changed N/A from a year ago — trailing twelve months through Dec 2022 was $700000.0 (changed N/A YoY), and the annual figure for FY2025 was -$576000.0, changed.
  • Other Non Operating Income for Q4 2021 was $1.4 million at Rani Therapeutics Holdings, up from -$700000.0 in the prior quarter.
  • Over the last five years, Other Non Operating Income for RANI hit a ceiling of $1.4 million in Q4 2021 and a floor of -$700000.0 in Q3 2021.